Bausch + Lomb
BLCOBausch + Lomb is a leading global eye health company that provides a comprehensive portfolio of products spanning the entire continuum of vision care.
Earnings
Next report
Date not yet announcedValuation & ratios
Segments
Competitors
By market cap
By revenue growth
Profile
Bausch + Lomb is a leading global eye health company that provides a comprehensive portfolio of products spanning the entire continuum of vision care. The company develops, manufactures, and markets a diverse range of contact lenses, ophthalmic pharmaceuticals, and surgical systems to treat conditions from birth through every phase of life. Its core value proposition centers on being a fully integrated eye health business with a significant global footprint and established brand equity.
A leading global eye health player with a fully integrated portfolio that covers the entire patient lifecycle and all major categories of the eye health market.
FAQ
- What is Bausch + Lomb's market cap?
- Bausch + Lomb (BLCO) has a market capitalization of $7.3B and trades on NYSE.
- What is Bausch + Lomb's revenue and profitability?
- Bausch + Lomb generated $5.4B in trailing twelve-month revenue with a net loss of $111.0M, representing a net margin of -2.0%, with free cash flow of $252.0M. The latest reported period is Q3 2026.
- Who are Bausch + Lomb's competitors?
- Bausch + Lomb's key competitors include CooperCompanies, Harrow, Inc. Common Stock, Ocular Therapeutix, Inc., and others. These companies compete in similar markets and product categories.
- Who does Bausch + Lomb partner with?
- Bausch + Lomb's notable partners include Novaliq GmbH, National Eye Institute.
- What subsidiaries does Bausch + Lomb have?
- Bausch + Lomb's subsidiaries include Bausch Health Companies Inc..
- Where is Bausch + Lomb headquartered?
- Bausch + Lomb is headquartered in Canada and employs approximately 13,300 people. It has been publicly traded since 2022.
